Horizon Discovery (Europe) Ltd.

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Acquired_by_PerkinElmer_in_2020
gptkbp:awards gptkb:Cambridge_News_Business_Excellence_Awards_2018
Best Company to Work For 2019
gptkbp:community_involvement Engages in local community projects.
Supports STEM education initiatives.
gptkbp:customerBase Academic institutions
Pharmaceutical companies
Biotechnology firms
gptkbp:employees Over 300 employees
gptkbp:events Hosts workshops on gene editing.
Participates in biotech conferences
gptkbp:financials Net income in 2020: £5 million
Revenue in 2020: £30 million
gptkbp:founded 2007
gptkbp:founder gptkb:Darrin_Disley
gptkbp:headquarters gptkb:Cambridge,_United_Kingdom
https://www.w3.org/2000/01/rdf-schema#label Horizon Discovery (Europe) Ltd.
gptkbp:industry Biotechnology
gptkbp:investmentFocus Institutional investors
Publicly_traded_on_the_London_Stock_Exchange
gptkbp:keyPeople gptkb:Mark_H._H._Hargreaves
gptkb:Katherine_Stowe
gptkb:Darrin_Disley
gptkbp:location gptkb:Cambridge_Science_Park
gptkb:United_Kingdom
Europe
gptkbp:mission To enable the advancement of life sciences.
gptkbp:partnerships Academic collaborations
Collaboration with pharmaceutical companies
gptkbp:products CRISPR technology
Cell models
Gene_editing_tools
gptkbp:publications Contributions to scientific literature.
Research papers in peer-reviewed journals.
gptkbp:research_focus Precision medicine
Therapeutic development
Genetic research
gptkbp:services Cell line development
Genomic services
Gene_editing
gptkbp:subsidiary gptkb:Horizon_Discovery_(Asia)_Ltd.
gptkb:Horizon_Discovery_Inc.
gptkb:Horizon_Discovery_(North_America)_Inc.
gptkbp:sustainability Focus on sustainable practices.
Commitment to reducing environmental impact.
gptkbp:technology gptkb:CRISPR/Cas9_technology
Cell line engineering
Gene_editing_technology
gptkbp:vision To be a leader in gene editing and genomic services.
gptkbp:website www.horizondiscovery.com